CLINICAL_TRIALS
trial_result
· 2016-06-14
Clinical Trial Update: A Safety and Efficacy Study of Eltrombopag in Subjects With AML [Phase 2]
Summary
Phase 2 trial update evaluating eltrombopag in subjects with acute leukaemia (AML).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Leukaemia | Phase 2 | Status: COMPLETED | Results posted: 2016-06-14